Paul Richard Gellert

This inventor holds 7 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Astrazeneca Ab, Array Biopharma Inc.. Active years: 2007-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul Richard Gellert. Retrieved from https://idiyas.com/inventor/paul-richard-gellert

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 (Patent Applications = 6)

% Patents Active = 85.7

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 3.1

ph-index = 2

Forward Citations = 8(Granted Patents)

Location History:

Cheshire, GB (2007)
Macclesfield, GB (2023)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2007-2025

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12465593 - Pharmaceutical composition (2025-11-11),

2. 12364684 - Pharmaceutical composition (2025-07-22),

3. 12318367 - Pharmaceutical composition (2025-06-03),

4. 12220403 - Pharmaceutical composition (2025-02-11),

5. 12115174 - Dendrimer formulations (2024-10-15),

6. 11813246 - Pharmaceutical composition (2023-11-14),

7. 7247491 - Method for determining release of a peptide from a sustained release polylactide formulation (2007-07-24),

Title: Paul Richard Gellert: Innovator in Pharmaceutical Compositions

Introduction

Paul Richard Gellert is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of pharmaceuticals, holding a total of 7 patents. His work focuses on innovative compositions that have the potential to improve medical treatments.

Latest Patents

Gellert's latest patents include a pharmaceutical composition that concerns a hydrogen sulphate salt of 6-(4-bromo-2-chloro-phenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxy-ethoxy)-amide. This invention also covers solvates, crystalline forms, and amorphous forms of the compound, emphasizing its use as a medicament and detailing processes for the preparation of these compositions.

Career Highlights

Throughout his career, Gellert has worked with prominent companies in the pharmaceutical industry, including AstraZeneca and Array Biopharma. His experience in these organizations has allowed him to develop and refine his innovative ideas in drug formulation.

Collaborations

Gellert has collaborated with several professionals in his field, including Kathryn Jane Hill and Nicola Frances Bateman. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Paul Richard Gellert is a distinguished inventor whose work in pharmaceutical compositions has the potential to impact medical science significantly. His innovative contributions and collaborations highlight his commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.